Velano Vascular Closes $5M Series A Financing

PrintVelano Vascular, a Philadelphia, PA and San Francisco, CA-based medical technology company, closed a $5m Series A financing.

Backers included First Round Capital, White Owl Capital, Kapor Capital, and Safeguard Scientifics (NYSE: SFE), in addition to angels and two hospitals.

The company plans to use proceeds to move into clinical evaluation and early commercialization with select hospital partners.

Founded in 2012 by Pitou Devgon, MD, president, and Eric M. Stone, chief executive officer, Velano Vasculars is advancing patented medical technology to reduce needle sticks during the inpatient blood draw procedure device and to enhance safety for providers.



Join the discussion